OpenAlex
PricingAboutJobs
Log inGet started
Author

L. Chen

Observed name: L Chen
Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute
Observed institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute
OpenAlex ID: A5016706978
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
2010 · A Scuto, P Krejci, et al. · Leukemia · 161
671 | Glofitamab for the Treatment of Relapsed/refractory Diffuse Large B Cell Lymphoma, a Real‐world Evidence Study From the Cubic Consortium
2025 · G. Shouse, S. Ahmed, et al. · Hematological Oncology · 3
PDF
813 | Phase Ii Investigator‐initiated Trial of Epcoritamab‐lenalidomide in Treatment Naïve Follicular Lymphoma
2025 · S. Thiruvengadam, L. Chen, et al. · Hematological Oncology
PDF
399 | Durvalumab and Lenalidomide Shows Superior Efficacy Over Single‐agent Durvalumab in Refractory/advanced Cutaneous T Cell Lymphoma: Results From a Randomized Phase 2 Trial
2025 · C. Querfeld, L. Chen, et al. · Hematological Oncology
PDF
Role Of Radiation In Relapses In Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) Post-Transplant
2020 · S.V. Dandapani, L. Chen, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 5
Citation count: 164
H-index: 2
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security